Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2016 Jun 28:6:28042.
doi: 10.1038/srep28042.

Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway

Affiliations
Clinical Trial

Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway

Trayambak Basak et al. Sci Rep. .

Abstract

Coronary artery disease (CAD) is one of the largest causes of death worldwide yet the traditional risk factors, although useful in identifying people at high risk, lack the desired predictive accuracy. Techniques like quantitative plasma proteomics holds immense potential to identify newer markers and this study (conducted in three phases) was aimed to identify differentially expressed proteins in stable CAD patients. In the first (discovery) phase, plasma from CAD cases (angiographically proven) and controls were subjected to iTRAQ based proteomic analysis. Proteins found to be differentially expressed were then validated in the second and third (verification and validation) phases in larger number of (n = 546) samples. After multivariate logistic regression adjusting for confounding factors (age, diet, etc.), four proteins involved in the reverse cholesterol pathway (Apo A1, ApoA4, Apo C1 and albumin) along with diabetes and hypertension were found to be significantly associated with CAD and could account for approximately 88% of the cases as revealed by ROC analysis. The maximum odds ratio was found to be 6.70 for albumin (p < 0.0001), followed by Apo AI (5.07, p < 0.0001), Apo CI (4.03, p = 0.001), and Apo AIV (2.63, p = 0.003). Down-regulation of apolipoproteins and albumin implicates the impairment of reverse cholesterol pathway in CAD.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Schematic workflow for the iTRAQ based discovery phase analysis.
Figure 2
Figure 2. Significantly (p < 0.0001) differentially expressed protein levels after logistic regression analysis.
Figure 3
Figure 3. A ROC curve showing area under the curve 0.8734 for CAD cases.

Similar articles

Cited by

References

    1. Vargas J. D. & Lima J. A. Coronary artery disease: a gene-expression score to predict obstructive CAD. Nature reviews. Cardiology 10, 243–244, doi: 10.1038/nrcardio.2013.50 (2013). - DOI - PubMed
    1. Garg G. et al.. Polymorphisms in transcobalamin II gene is associated with coronary artery disease in Indian population. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals 17, 119–124, doi: 10.3109/1354750X.2011.642408 (2012). - DOI - PubMed
    1. Butler D. UN targets top killers. Nature 477, 260–261, doi: 10.1038/477260a (2011). - DOI - PubMed
    1. Lim S. S. et al.. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224–2260, doi: 10.1016/S0140-6736(12)61766-8 (2012). - DOI - PMC - PubMed
    1. Kullo I. J. & Cooper L. T. Early identification of cardiovascular risk using genomics and proteomics. Nature reviews. Cardiology 7, 309–317, doi: 10.1038/nrcardio.2010.53 (2010). - DOI - PMC - PubMed

Publication types